Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection

PURPOSE: The aim of this study was to identify and validate novel predictive and/or prognostic serum proteomic biomarkers in patients with epithelial ovarian cancer (EOC) treated as part of the phase III international ICON7 clinical trial. EXPERIMENTAL DESIGN: ICON7 was a phase III international tri...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Collinson, Fiona, Hutchinson, Michelle, Craven, Rachel A., Cairns, David A., Zougman, Alexandre, Wind, Tobias C., Gahir, Narinder, Messenger, Michael P., Jackson, Sharon, Thompson, Douglas, Adusei, Cybil, Ledermann, Jonathan, Hall, Geoffrey, Jayson, Gordon C., Selby, Peter J., Banks, Rosamonde E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780518/
https://ncbi.nlm.nih.gov/pubmed/23935036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0489
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak